Markus Eberl

Munich, BY 80687, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Data on Ocrelizumab Treatment Collected by MS Patients in Germany Using Brisa App.

Data on Ocrelizumab Treatment Collected by MS Patients in Germany Using Brisa App.

Journal: Journal of personalized medicine

Published: March 22, 2024

Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany.

Shifting from the treat-to-target to the early highly effective treatment approach in patients with multiple sclerosis - real-world evidence from Germany.

Journal: Therapeutic advances in neurological disorders

Published: November 24, 2023

Preclinical study of CD19 detection methods post tafasitamab treatment.

Preclinical study of CD19 detection methods post tafasitamab treatment.

Journal: Frontiers in immunology

Published: August 08, 2023

The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany.

The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany.

Journal: Dermatology and therapy

Published: July 17, 2023

Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.

Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: June 13, 2023

Drug switching in axial spondyloarthritis patients in Germany - a social listening analysis.

Drug switching in axial spondyloarthritis patients in Germany - a social listening analysis.

Journal: Therapeutic advances in musculoskeletal disease

Published: February 10, 2023

The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany.

The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 01, 2022

Real-world demographic patterns of users of a digital primary prevention service for diabetes.

Real-world demographic patterns of users of a digital primary prevention service for diabetes.

Journal: Cardiovascular endocrinology & metabolism

Published: August 05, 2022

Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app.

Correlation and differences of patient-reported outcomes vs. Likert-Rating of MS symptoms in a real-world cohort using a digital patient app.

Journal: Digital health

Published: July 01, 2022

Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany.

Demographic Patterns of MS Patients Using BRISA: An MS-Specific App in Germany.

Journal: Journal of personalized medicine

Published: June 02, 2022

A retrospective real-world observational pilot analysis of Waya: a self-monitoring fitness app in Germany.

A retrospective real-world observational pilot analysis of Waya: a self-monitoring fitness app in Germany.

Journal: Cardiovascular endocrinology & metabolism

Published: March 08, 2022

Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.

Basal cell carcinomas acquire secondary mutations to overcome dormancy and progress from microscopic to macroscopic disease.

Journal: Cell reports

Published: January 28, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026